TrajOnco: a multi-agent framework for temporal reasoning over longitudinal EHR for multi-cancer early detection

Accurate estimation of cancer risk from longitudinal electronic health records (EHRs) could support earlier detection and improved care, but modeling such complex patient trajectories remains challenging. We present TrajOnco, a training-free, multi-agent large language model (LLM) framework designed for scalable multi-cancer early detection. Using a chain-of-agents architecture with long-term memory, TrajOnco performs temporal reasoning over sequential clinical events to generate patient-level summaries, evidence-linked rationales, and predicted risk scores. We evaluated TrajOnco on de-identified Truveta EHR data across 15 cancer types using matched case-control cohorts, predicting risk of cancer diagnosis at 1 year. In zero-shot evaluation, TrajOnco achieved AUROCs of 0.64-0.80, performing comparably to supervised machine learning in a lung cancer benchmark while demonstrating better temporal reasoning than single-agent LLMs. The multi-agent design also enabled effective temporal reasoning with smaller-capacity models such as GPT-4.1-mini. The fidelity of TrajOnco's output was validated through human evaluation. Furthermore, TrajOnco's interpretable reasoning outputs can be aggregated to reveal population-level risk patterns that align with established clinical knowledge. These findings highlight the potential of multi-agent LLMs to execute interpretable temporal reasoning over longitudinal EHRs, advancing both scalable multi-cancer early detection and clinical insight generation.

TrajSurv: Learning Continuous Latent Trajectories from Electronic Health Records for Trustworthy Survival Prediction

Trustworthy survival prediction is essential for clinical decision making. Longitudinal electronic health records (EHRs) provide a uniquely powerful opportunity for the prediction. However, it is challenging to accurately model the continuous clinical progression of patients underlying the irregularly sampled clinical features and to transparently link the progression to survival outcomes. To address these challenges, we develop TrajSurv, a model that learns continuous latent trajectories from longitudinal EHR data for trustworthy survival prediction. TrajSurv employs a neural controlled differential equation (NCDE) to extract continuous-time latent states from the irregularly sampled data, forming continuous latent trajectories. To ensure the latent trajectories reflect the clinical progression, TrajSurv aligns the latent state space with patient state space through a time-aware contrastive learning approach. To transparently link clinical progression to the survival outcome, TrajSurv uses latent trajectories in a two-step divide-and-conquer interpretation process. First, it explains how the changes in clinical features translate into the latent trajectory's evolution using a learned vector field. Second, it clusters these latent trajectories to identify key clinical progression patterns associated with different survival outcomes. Evaluations on two real-world medical datasets, MIMIC-III and eICU, show TrajSurv's competitive accuracy and superior transparency over existing deep learning methods.